Naftali Kaminski Selected Research

Asthma (Bronchial Asthma)

10/2023	Genetic analyses of chr11p15.5 region identify MUC5AC-MUC5B associated with asthma-related phenotypes.
1/2023	Low CC16 mRNA Expression Levels in Bronchial Epithelial Cells Are Associated with Asthma Severity.
11/2021	Machine learning implicates the IL-18 signaling axis in severe asthma.
1/2021	Genetic analyses identify GSDMB associated with asthma severity, exacerbations, and antiviral pathways.
1/2020	Expression of SARS-CoV-2 receptor ACE2 and coincident host response signature varies by asthma inflammatory phenotype.
1/2019	Sialylation of MUC4β N-glycans by ST6GAL1 orchestrates human airway epithelial cell differentiation associated with type-2 inflammation.
1/2017	Gene Expression Correlated with Severe Asthma Characteristics Reveals Heterogeneous Mechanisms of Severe Disease.
1/2017	Toward Precision Medicine of Symptom Control in Asthma.
10/2016	Expression of asthma susceptibility genes in bronchial epithelial cells and bronchial alveolar lavage in the Severe Asthma Research Program (SARP) cohort.
12/2014	Gene expression in relation to exhaled nitric oxide identifies novel asthma phenotypes with unique biomolecular pathways.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Naftali Kaminski Research Topics

Disease

58	Idiopathic Pulmonary Fibrosis 01/2024 - 04/2002
56	Fibrosis (Cirrhosis) 03/2024 - 02/2003
34	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2023 - 03/2002
16	Inflammation (Inflammations) 01/2023 - 07/2003
16	Lung Diseases (Lung Disease) 01/2022 - 03/2003
15	Chronic Obstructive Pulmonary Disease (COPD) 11/2023 - 05/2007
14	Sarcoidosis (Schaumann Disease) 12/2023 - 09/2013
13	Lung Injury 01/2023 - 02/2008
12	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2024 - 01/2006
11	Asthma (Bronchial Asthma) 10/2023 - 03/2008
11	Neoplasms (Cancer) 01/2022 - 07/2004
9	Disease Progression 01/2023 - 04/2007
8	COVID-19 01/2023 - 10/2020
8	Acute Lung Injury 01/2021 - 07/2010
8	Lung Neoplasms (Lung Cancer) 01/2019 - 07/2004
6	Emphysema 01/2023 - 03/2003
5	Infections 01/2024 - 12/2017
4	Hypoxia (Hypoxemia) 01/2024 - 12/2008
3	Hyperoxia 01/2023 - 03/2016
3	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 01/2022 - 01/2006
3	Communicable Diseases (Infectious Diseases) 01/2022 - 10/2020
3	Virus Diseases (Viral Diseases) 06/2021 - 04/2020
3	Granuloma 01/2021 - 09/2013
3	Cystic Fibrosis (Mucoviscidosis) 11/2020 - 11/2018
3	Pulmonary Hypertension 01/2018 - 04/2010
3	Carcinogenesis 08/2012 - 02/2003
3	Multiple Sclerosis 04/2007 - 05/2002
2	Pulmonary Sarcoidosis 12/2021 - 01/2021
2	Cicatrix (Scar) 01/2021 - 01/2020
2	Bronchiolitis Obliterans Syndrome 01/2021 - 11/2018
2	Death (Near-Death Experience) 01/2019 - 02/2015
2	Chronic Disease (Chronic Diseases) 01/2019 - 05/2002
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 11/2013 - 06/2006
2	Pulmonary Emphysema 09/2012 - 03/2003
2	Myositis (Idiopathic Inflammatory Myopathies) 06/2010 - 07/2009

Drug/Important Bio-Agent (IBA)

37	Bleomycin (Blenoxane)FDA LinkGeneric 03/2024 - 04/2002
27	Biomarkers (Surrogate Marker)IBA 12/2023 - 04/2007
21	RNA (Ribonucleic Acid)IBA 11/2023 - 04/2010
18	Proteins (Proteins, Gene)FDA Link 03/2024 - 07/2004
18	MicroRNAs (MicroRNA)IBA 11/2023 - 07/2010
16	CollagenIBA 11/2023 - 07/2003
8	CytokinesIBA 11/2023 - 05/2002
8	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2023 - 06/2008
6	Messenger RNA (mRNA)IBA 03/2024 - 04/2014
6	indium-bleomycinIBA 07/2023 - 12/2004
6	Transcription Factors (Transcription Factor)IBA 06/2021 - 05/2009
6	OligonucleotidesIBA 08/2012 - 03/2002
5	Transforming Growth Factor beta (TGF-beta)IBA 03/2024 - 03/2003
5	LigandsIBA 11/2023 - 12/2010
5	InterferonsIBA 06/2021 - 02/2005
5	EnzymesIBA 01/2018 - 01/2008
4	ChemokinesIBA 11/2023 - 07/2009
4	SmokeIBA 01/2022 - 09/2012
4	Blood Proteins (Serum Proteins)IBA 04/2021 - 07/2009
4	Hydroxyproline (4 Hydroxyproline)IBA 11/2019 - 12/2006
4	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 08/2008
3	Interleukin-6 (Interleukin 6)IBA 03/2024 - 05/2002
3	HLA Antigens (Human Leukocyte Antigens)IBA 01/2024 - 02/2011
3	Mitochondrial DNA (mtDNA)IBA 11/2023 - 12/2017
3	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2023 - 11/2021
3	Protein Isoforms (Isoforms)IBA 11/2023 - 10/2014
3	Small Cytoplasmic RNAIBA 08/2023 - 10/2021
3	Thyroid HormonesIBA 01/2023 - 01/2018
3	pirfenidoneIBA 12/2022 - 02/2015
3	IntegrinsIBA 11/2017 - 03/2003
3	Matrix Metalloproteinase 7 (Matrilysin)IBA 11/2017 - 04/2002
3	Peptide Hydrolases (Proteases)FDA Link 06/2015 - 09/2009
3	Matrix Metalloproteinases (MMPs)IBA 10/2014 - 07/2009
3	Interferon-gamma (Interferon, gamma)IBA 07/2009 - 05/2002
2	Interleukin-17 (Interleukin 17)IBA 03/2024 - 01/2018
2	HLA-DQB1 antigen (HLA DQB1)IBA 01/2024 - 07/2023
2	Hormones (Hormone)IBA 11/2023 - 12/2008
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2023 - 12/2014
2	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2023 - 01/2021
2	src-Family KinasesIBA 01/2023 - 12/2022
2	nintedanibIBA 12/2022 - 02/2015
2	Oxygen (Dioxygen)IBA 01/2022 - 01/2019
2	Tacrolimus Binding Proteins (FKBP)IBA 01/2022 - 08/2015
2	tocilizumab (atlizumab)FDA Link 01/2022 - 10/2020
2	InterleukinsIBA 12/2021 - 11/2013
2	Interleukin-18 (Interleukin 18)IBA 12/2021 - 11/2021
2	Antigen Receptors (Antigen Receptor)IBA 11/2021 - 04/2021
2	AlarminsIBA 11/2021 - 04/2021
2	Complement System Proteins (Complement)IBA 04/2021 - 01/2021
2	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2021
2	Interleukin-13IBA 01/2019 - 10/2016
2	AntigensIBA 12/2017 - 01/2010
2	SteroidsIBA 01/2017 - 12/2008
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 09/2014 - 09/2013
2	AntibodiesIBA 04/2013 - 07/2009
2	ChlorineIBA 08/2012 - 07/2010
2	Acrolein (Aqualin)IBA 09/2011 - 06/2011
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 03/2008 - 02/2003

Therapy/Procedure

27	Therapeutics 03/2024 - 05/2002
5	Transplantation 01/2020 - 07/2009
4	Immunotherapy 01/2022 - 05/2015
4	Lung Transplantation 01/2021 - 04/2008
4	Precision Medicine 01/2017 - 08/2012
2	Palliative Care (Palliative Therapy) 01/2019 - 02/2015
2	Artificial Respiration (Mechanical Ventilation) 02/2008 - 06/2006